α-SMA |
α- smooth muscle actin |
BM-MSCs |
Bone marrow-derived mesenchymal stem cells |
CAF |
Cancer-associated fibroblast |
CK |
cytokeratin |
CTC |
Circulating Tumor Cell |
CXCL9 |
C-X-C Motif Chemokine Ligand 9 |
CXCL12 |
C-X-C Motif Chemokine Ligand 12 |
CXCL12 |
C-X-C Motif Chemokine Ligand 14 |
DAPI |
4′,6-diamidino-2-phenylindole |
ECM |
Extracellular matrix |
EMP |
Epithelial–mesenchymal plasticity |
EMT |
Epithelial-to-mesenchymal transition |
EV |
Extracellular vesicle |
FAK |
Focal Adhesion Kinase |
FAP |
Fibroblast activation protein |
FGF |
Fibroblast growth factor |
FSP |
Fibroblast specific protein |
IL-6 |
Interleukin 6 |
LN |
lymph nodes |
LncRNA |
Long non-coding RNAs |
miRNA |
microRNA |
MMP |
Matrix metalloproteinases |
NGS |
Next generation sequencing |
PDGFC |
Platelet-derived growth factor |
PDGFRα |
platelet-derived growth factor receptor-α |
PDGFRβ |
Platelet-derived growth factor receptor-β |
PMN-MDSCs |
Polymorphonuclear-myeloid-derived suppressor cells |
SDF-1 |
Stromal cell-derived factor 1 |
SRC |
SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase |
TAMs |
Tumor-associated macrophages |
TGF-β |
Transforming growth factor-β |
TME |
Tumor microenvironment |
VEGF |
vascular endothelial growth factor |
VEGFR1 |
Vascular endothelial growth factor receptor 1 |
WBC |
White blood cell |